candesartan cilexetil has been researched along with Hypertrophy in 5 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertrophy was estimated by immunohistochemical staining of alpha-actin." | 5.29 | The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats. ( Higaki, J; Mikami, H; Morishita, R; Ogihara, T; Rakugi, H; Yu, H, 1993) |
| "Vascular hypertrophy is considered to be an adaptive response to increased arterial wall stress in hypertension." | 1.30 | Effect of angiotensin II receptor antagonism on vascular hypertrophy and aortic impedance in abdominal aortic-banded rat. ( Kobayashi, S; Kohno, M; Konishi, M; Matsuzaki, M; Obayashi, M; Ohkusa, T; Yamamoto, T; Yano, M, 1999) |
| "Hypertrophy was estimated by immunohistochemical staining of alpha-actin." | 1.29 | The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats. ( Higaki, J; Mikami, H; Morishita, R; Ogihara, T; Rakugi, H; Yu, H, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shweta, A | 1 |
| Cullen-McEwen, LA | 1 |
| Kett, MM | 1 |
| Evans, RG | 1 |
| Denton, KM | 1 |
| Fitzgerald, SM | 1 |
| Anderson, WP | 1 |
| Bertram, JF | 1 |
| Jones, ES | 1 |
| Black, MJ | 1 |
| Widdop, RE | 1 |
| Nakamura, F | 1 |
| Nagano, M | 1 |
| Kobayashi, R | 1 |
| Higaki, J | 2 |
| Mikami, H | 2 |
| Kawaguchi, N | 1 |
| Onishi, S | 1 |
| Ogihara, T | 2 |
| Yu, H | 1 |
| Rakugi, H | 1 |
| Morishita, R | 1 |
| Obayashi, M | 1 |
| Yano, M | 1 |
| Kohno, M | 1 |
| Kobayashi, S | 1 |
| Yamamoto, T | 1 |
| Ohkusa, T | 1 |
| Konishi, M | 1 |
| Matsuzaki, M | 1 |
5 other studies available for candesartan cilexetil and Hypertrophy
| Article | Year |
|---|---|
Glomerular surface area is normalized in mice born with a nephron deficit: no role for AT1 receptors.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds | 2009 |
Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Block | 2004 |
Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardi | 1994 |
The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats.
Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; | 1993 |
Effect of angiotensin II receptor antagonism on vascular hypertrophy and aortic impedance in abdominal aortic-banded rat.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Abdominal; Benzimidazoles | 1999 |